The Growth Investor Daily Brief

Tractian, Tenstorrent, and Maze Therapeutics: Series C+ Funding Highlights

5 min · 5 de dic de 2024
Portada del episodio Tractian, Tenstorrent, and Maze Therapeutics: Series C+ Funding Highlights

Descripción

Michelle starts with an introduction and welcome, leading into the latest Series C+ funding highlights. The episode features Tractian's funding achievements, alongside updates on Tenstorrent and Maze Therapeutics. In between, there's a brief mention of the episode's sponsor, Acme Corp. Michelle wraps up with closing remarks, providing listeners with a comprehensive overview of these significant funding developments in the startup ecosystem. (0:00) Introduction and welcome (0:12) Series C+ funding highlights: Tractian, Tenstorrent, and Maze Therapeutics (3:19) Sponsor: Acme Corp (5:24) Wrap-up and closing remarks

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de The Growth Investor Daily Brief!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

9 episodios

episode Axiado, ModifyHealth, Cleerly, and Tenstorrent: Series C+ Funding Highlights and Future Prospects artwork

Axiado, ModifyHealth, Cleerly, and Tenstorrent: Series C+ Funding Highlights and Future Prospects

Michelle introduces the latest episode of The Growth Investor Daily Brief, focusing on companies that have recently secured Series C+ funding. The episode highlights Axiado's Series C funding and their strategic expansion plans, along with ModifyHealth's Series C success and their outlined growth trajectory. Additionally, Cleerly's innovative AI technology and insights into their Series C funding are discussed. The episode also covers Tenstorrent's impressive Series D round, exploring their future prospects in the industry. Michelle concludes with closing remarks and a call to action, urging listeners to stay updated on the latest trends in startup funding. (0:00) Introduction to The Growth Investor Daily Brief (0:12) Companies securing Series C+ funding highlights (1:21) Axiado's Series C funding and expansion strategy (2:11) ModifyHealth's Series C success and growth plans (3:38) Cleerly's AI technology and Series C funding insights (5:26) Tenstorrent's massive Series D round and future prospects (6:56) Closing remarks and call to action

6 de dic de 20247 min
episode OneRail, Tenstorrent, and Maze Therapeutics: Series C+ Funding and Future Plans artwork

OneRail, Tenstorrent, and Maze Therapeutics: Series C+ Funding and Future Plans

Michelle welcomes listeners to the latest episode of The Growth Investor Daily Brief, diving into recent Series C+ funding updates. The episode covers OneRail's efforts in optimizing last-mile delivery and their funding plans, as well as Tenstorrent's Series D success in the AI chip sector. Additionally, Maze Therapeutics' Series D financing and their future strategic plans are discussed. The episode wraps up with investor insights, providing listeners with essential information to stay informed about the evolving investment landscape. (0:00) Welcome to The Growth Investor Daily Brief (0:13) Series C+ funding updates: OneRail, Tenstorrent, and Maze Therapeutics (0:39) OneRail's optimization of last-mile delivery and funding plans (1:21) Tenstorrent's Series D success in the AI chip sector (2:22) Maze Therapeutics' Series D financing and future plans (5:14) Investor insights and episode wrap-up

4 de dic de 20245 min
episode Halcyon and Tenstorrent: Series C and D Funding Rounds & AI Innovation Insights artwork

Halcyon and Tenstorrent: Series C and D Funding Rounds & AI Innovation Insights

Michelle begins with an introduction and highlights recent Series C+ funding rounds. She delves into Halcyon's Series C funding, discussing the company's growth trajectory and strategic initiatives. The episode also covers Tenstorrent's Series D funding round, exploring their AI innovations and future funding plans. Michelle concludes with a call to action, encouraging listeners to stay informed on the latest investment trends shaping the tech industry. HELLO title [https://www.example.com] (0:00) Introduction and Series C+ funding highlights (0:21) Halcyon's Series C and Tenstorrent's Series D funding rounds (1:44) Tenstorrent's AI innovation and funding plans (2:38) Conclusion and call to action

3 de dic de 20242 min